COMBAT - Updated biosecurity tool with 4 features
Read nowWinners of the 8th European PRRS Research Award
- 2 minutes
- EU 2021 | European PRRS Research Awards
Boehringer Ingelheim honors three research proposals with a total funding of 75,000 euro (25,000 euro each) to encourage further development of practical methods for controlling PRRS (Porcine Reproductive and Respiratory Syndrome), and to recognize scientific accomplishments in this field.
What have we learned about PRRS resiliance?
- 22 minutes
- Asian PRRSpective | AS 2017
- Dr. Carlo Maala
11th Asian PRRSpective 2017 · Improving PRRS resilience in pig farms
Episode 3 - PCV2: What do the different genotypes mean in the field?
- Podcast in Episodes
- Quim Segalés
“So far, all vaccines in the market have shown great efficacy in reducing clinical signs associated to diseases caused by PCV-2, independently of the genotype present in the farm. Moreover, experimental data demonstrated the cross-protection of PCV-2a vaccines against the most widespread genotypes (PCV-2a, PCV-2b, and PCV-2d). Therefore, despite the significant number of genotypes described/proposed (PCV-2a to PCV-2i), it seems one single PCV-2 serotype would exist"
Finding PRRSV in sow herds: Family oral fluids vs. serum samples from due-to-wean pigs
- Expertise article
- M. N. Almeida et al.
The aim of this study was to compare the detection of porcine reproductive and respiratory syndrome virus (PRRSV) in due-to-wean litters in commercial swine breeding herds.
Don’t miss any news on PRRS disease control Subscribe now to PRRS.com newsletter
Guilty Guilt Guide
The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
Advanced Research in Porcine Reproductive and Respiratory Syndrome Virus Co-infection With Other Pathogens in Swine
- Top publications | September
- Dengshuai Zhao, Bo Yang, Xingguo Yuan, Chaochao Shen, Dajun Zhang, Xijuan Shi, Ting Zhang, Huimei Cui, Jinke Yang, Xuehui Chen, Yu Hao, Haixue Zheng, Keshan Zhang and Xiangtao Liu
The porcine reproductive and respiratory syndrome virus (PRRSV) is the pathogen causing epidemics of porcine reproductive and respiratory syndrome (PRRS), and is present in every major swine-farming country in the world. Previous studies have demonstrated that PRRSV infection leads to a range of consequences, such as persistent infection, secondary infection, and co-infection, and is common among pigs in the field. In recent years, coinfection of PRRSV and other porcine pathogens has occurred often, making it more difficult to define and diagnose PRRSV-related diseases. The study of coinfections may be extremely suitable for the current prevention and control in the field. However, there is a limited understanding of coinfection. Therefore, in this review, we have focused on the epidemiology of PRRSV coinfection with other pathogens in swine, both in vivo and in vitro.
Effect of multiple vaccinations on transmission and degree of Mycoplasma hyopneumoniae infection in gilts
- Expertise article
- Betlach et al.
Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in significant respiratory challenges in the swine industry worldwide. Vaccination for M. hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae vaccination on transmission across different pig populations has been minimally investigated.
Modeling Economic Effects of Vaccination Against Porcine Reproductive and Respiratory Syndrome: Impact of Vaccination Effectiveness, Vaccine Price, and Vaccination Coverage
- Expertise article
- Thomann et al., 2020
Porcine reproductive and respiratory syndrome (PRRS) causes substantial financial losses in pig farms and economic losses to societies worldwide. Vaccination against PRRS virus (PRRSV) is a common intervention in affected farms.